Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eighteen research firms that are presently covering the stock, ...

On Thursday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $28.59 which represents a decrease of $-1.08 or -3.64% from the prior close of $29.67. The stock opened at $29.63 ...

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.4.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

SAN DIEGO, October 30, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and ...

Susan Morrison; Executive Vice President, Chief Administrative Officer; Tandem Diabetes Care Inc John Sheridan; President, Chief Executive Officer, Director; Tandem Diabetes Care Inc Leigh ...

Fintel reports that on November 6, 2024, Bernstein initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today ...